However, these factors have little bearing on the clinical, histologic, demographic, and biologic profiles associated with primary mucosal malignant melanoma
Family Medicine Physician with 20+ years in Family Medicine focused on metabolic health and medical weight management
Ten years from now, when we look back at this decade, GLP-1 therapies may be remembered as one of the biggest shifts in modern medicine
GLP-1 receptor agonists have demonstrated significant weight loss results in clinical trials, with participants losing 15% to 22% of body weight over 68 weeks
General adverse events The most frequently reported adverse reactions across trials included gastrointestinal events such as nausea, diarrhea, vomiting, constipation, and abdominal pain